Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model.
Sci Transl Med. 2022 Aug 17;14(658):eabn6868. doi: 10.1126/scitranslmed.abn6868. Epub 2022 Aug 17.
Sci Transl Med. 2022.
PMID: 35511920
Free PMC article.
Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model.
Johnson S, Martinez CI, Tedjakusuma SN, Peinovich N, Dora EG, Birch SM, Kajon AE, Werts AD, Tucker SN.
Johnson S, et al. Among authors: tedjakusuma sn.
J Infect Dis. 2022 Jan 5;225(1):34-41. doi: 10.1093/infdis/jiab561.
J Infect Dis. 2022.
PMID: 34758086
Free PMC article.
Item in Clipboard
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates.
Tedjakusuma SN, Lester CA, Neuhaus ED, Dora EG, Gutierrez S, Braun MR, Tucker SN, Flitter BA.
Tedjakusuma SN, et al.
Vaccines (Basel). 2024 Jan 27;12(2):132. doi: 10.3390/vaccines12020132.
Vaccines (Basel). 2024.
PMID: 38400116
Free PMC article.
Item in Clipboard
Cite
Cite